Companies: 10,795·Total market cap: $144.5T
Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp.

ATTBFOTCHealthcare● Active
$0.00
+$0.00(+2900.00%)
Market Cap$14334
P/E Ratio—
52W High$0.0001
52W Low$0.000001
EarningsFinancialsRevenue

Abattis Bioceuticals Corp. (ATTBF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

ATTBF · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
PeriodLowConsensusHigh# Analysts
Q3 FY2024$2.09$2.09$2.091
Q2 FY2024$1.83$1.83$1.831
Q1 FY2024$2.14$2.14$2.141
Q4 FY2023$3.00$3.00$3.001
Q3 FY2023$1.88$1.88$1.881
Q2 FY2023$1.58$1.58$1.581
Revenue Estimates
PeriodLowConsensusHigh# Analysts
Q3 FY2024$0.0B$0.0B$0.0B1
Q2 FY2024$0.0B$0.0B$0.0B1
Q1 FY2024$0.0B$0.0B$0.0B1
Q4 FY2023$0.0B$0.0B$0.0B1
Q3 FY2023$0.0B$0.0B$0.0B1
Q2 FY2023$0.0B$0.0B$0.0B1

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: ATTBF ends December

Abattis Bioceuticals Corp. (ATTBF) reports earnings quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. The next ATTBF earnings date is expected around September 1, 2026.

Each quarter, investors track ATTBF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ATTBF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ATTBF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

ATTBF earnings · 3 questions

Abattis Bioceuticals Corp.'s next earnings report is expected around September 1, 2026. ATTBF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ATTBF historically reports after market close (AMC).

ATTBF earnings datewhen is ATTBF earningsATTBF next earnings datewhen does ATTBF report earningsATTBF earnings calendar

▸ Source: FMP · Abattis Bioceuticals Corp. SEC filings · US GAAP · Abattis Bioceuticals Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026